Government of Canada and JDRF Create Partnership to Defeat Diabetes
Building a strong partnership to accelerate type 1 diabetes clinical trials research
The Honourable Jane Philpott, Minister of Health, announced on April 10 that the Government of Canada is investing in a new partnership that will help improve health outcomes and quality of care for the more than 300,000 Canadians living with type 1 diabetes (T1D) and their families. The Government, through the Canadian Institutes of Health Research (CIHR) and JDRF Canada, is creating a Partnership to Defeat Diabetes to support innovative clinical trials research for T1D. Both CIHR and JDRF have committed $15M to the partnership, for a total investment of $30M.
"The Government of Canada recognizes the impact that T1D has on Canadians and their families,” says Minister Philpott. “This research will help improve the quality of life for Canadians living with T1D and drive efforts to find a cure for the condition.”
"CIHR is proud to be working with JDRF to support research on T1D,” says Dr. Philip Sherman, scientific director of the CIHR Institute of Nutrition, Metabolism and Diabetes. “This new partnership will focus the efforts of the diabetes research community in Canada, and speed the development of new and better treatments.”
“As a representative of the T1D community, and someone who has lived with T1D for over 30 years, I am pleased and thrilled to see the commitment both JDRF and the Government of Canada are putting towards clinical trials research,” says Juno award winner and JDRF Canada spokesperson, George Canyon. “It is my hope that one day it will lead to a cure for this life-altering condition.”
JDRF and CIHR share a vision of improved care, outcomes and treatment for Canadians through innovative T1D research, which will advance the search for a cure. This new collaboration with CIHR builds upon the success of JDRF's Canadian Clinical Trials Network (CCTN) and helps maintain Canada's leadership in T1D research and clinical trials. “We are honoured to partner with CIHR to continue funding the best and brightest scientists in the field,” says Dave Prowten, President and CEO at JDRF Canada. “This partnership will enable JDRF Canada to make significant advancements in the fight against T1D and to positively impact the lives of the hundreds of thousands of Canadians currently living with the disease.”
“Canada is known for its state-of-the-art T1D research, and has played a pivotal role in ground-breaking discoveries,” adds Derek Rapp, CEO at JDRF International. “We are pleased to be entering into this exciting partnership with CIHR to advance global science excellence.”
Specific information about the grants available under this new program will be posted on CIHR’s website.
Every contribution helps bring us closer to a cure.